Novel pyrazole compounds, including derivatives thereof, to intermediates
for their preparation, to pharmaceutical compositions containing them and
to their medicinal use are described. The compounds of the present
invention are potent inhibitors of transforming growth factor
("TGF")-.beta. signaling pathway. They are useful in the treatment of
various TGF-related disease states including, for example, cancer, and
fibrotic diseases.